1977 Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC). (September 2015) - Bardia, A.; Cameron, J.S.; Venkatesan, K.; Robinson, D.; Porter, D.; Kim, S.B.; Parton, M.; Kümmel, S.; Estevez, L.G.; Huang, C.S.; Cortes Castan, J.; Ruiz-Borrego, M.; et al.